Endogenous Steroid Hormone Concentrations and Risk of Endometriosis in Nurses' Health Study II.

ABSTRACT

Few studies have assessed the association between endogenous steroid hormone levels and a subsequent diagnosis of endometriosis. We prospectively evaluated premenopausal plasma sex hormone levels and the risk of laparoscopically confirmed endometriosis in a nested case-control study within Nurses' Health Study II. Between blood collection (1996-1999) and 2009, we ascertained 446 women with incident endometriosis and matched them to 878 controls through risk-set sampling. We conducted multivariable conditional logistic regression accounting for matching and confounders to estimate relative risks (RRs) and 95% confidence intervals (CIs). Women with greater early follicular-phase total or free estradiol levels had a nonlinear increased risk of endometriosis (early follicular total estradiol second quartile vs. first, RR = 2.23 (95% CI 1.44, 3.47); third quartile, RR = 1.83 (95% CI 1.16, 2.88); fourth quartile, RR = 1.68 (95% CI 1.05, 2.68); early follicular free estradiol second quartile vs. first, RR = 1.63 (95% CI 1.05, 2.54); third quartile, RR = 2.02 (95% CI 1.31, 3.12); fourth quartile, RR = 1.04 (95% CI 0.66, 1.65)). Free testosterone assessed in quartile categories was not associated with endometriosis, although a threshold effect was observed, with a positive association among women in the top 2% of free testosterone levels. Levels of mid-luteal-phase total and free estradiol, follicular and luteal estrone, total testosterone, progesterone, and sex hormone binding globulin were not associated with endometriosis risk. These results support the role of sex steroids in endometriosis etiology, although the relationships suggest complex threshold effects.